Back
Relmada Therapeutics, Inc. 10K Form
Sell
32
RLMD
Relmada Therapeutics, Inc.
Last Price:
$3.99
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RLMD News And Ratings
See the #1 stock for the next 7 days that we like better than RLMD
RLMD Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.29 |
| Price / Book: | 30.99 |
Profitability
| EPS (TTM): | -1.79700 |
|---|---|
| Net Income (TTM): | $-56.2M |
| Gross Margin: | $0 |
| Return on Equity: | -214.4% |
| Return on Assets: | -170.01% |
Relmada Therapeutics, Inc. Earnings Forecast
Key Relmada Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Relmada Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RLMD |
| CUSIP: | 75955J |
| Website: | relmada.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.86 |
| Quick Ratio: | 2.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RLMD Technical Analysis vs Fundamental Analysis
Sell
32
Relmada Therapeutics, Inc. (RLMD)
is a Sell
Is Relmada Therapeutics, Inc. a Buy or a Sell?
-
Relmada Therapeutics, Inc. stock is rated a SellThe current Relmada Therapeutics, Inc. [RLMD] share price is $4.00. The Score for RLMD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.